Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.

Wennersten, Christoffer ; Andersson, Gustav LU ; Boman, Karolina LU ; Nodin, Björn LU ; Gaber, Alexander LU and Jirström, Karin LU orcid (2014) In Diagnostic Pathology 9(1).
Abstract
Reduced membranous expression of the cytoskeleton-associated protein ezrin has previously been demonstrated to correlate with poor prognosis in urothelial bladder cancer in several independent studies. The present study provides a first description of clinicopathological characteristics of incident urothelial cancers, not only located to the bladder, in the prospective, population-based cohort study Malmö Diet and Cancer. In addition, the prognostic value of ezrin expression is validated in primary tumours, and the longitudinal expression of ezrin examined in a subset of primary and recurrent tumours (n = 28).
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diagnostic Pathology
volume
9
issue
1
article number
189
publisher
BioMed Central (BMC)
external identifiers
  • pmid:25278252
  • wos:000343803700001
  • scopus:84907960550
  • pmid:25278252
ISSN
1746-1596
DOI
10.1186/s13000-014-0189-5
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology, (Lund) (013030000)
id
7f6c9d7c-0827-4876-8287-a6ffb5fcdb17 (old id 4738454)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25278252?dopt=Abstract
date added to LUP
2016-04-01 13:41:35
date last changed
2024-01-29 02:52:46
@article{7f6c9d7c-0827-4876-8287-a6ffb5fcdb17,
  abstract     = {{Reduced membranous expression of the cytoskeleton-associated protein ezrin has previously been demonstrated to correlate with poor prognosis in urothelial bladder cancer in several independent studies. The present study provides a first description of clinicopathological characteristics of incident urothelial cancers, not only located to the bladder, in the prospective, population-based cohort study Malmö Diet and Cancer. In addition, the prognostic value of ezrin expression is validated in primary tumours, and the longitudinal expression of ezrin examined in a subset of primary and recurrent tumours (n = 28).}},
  author       = {{Wennersten, Christoffer and Andersson, Gustav and Boman, Karolina and Nodin, Björn and Gaber, Alexander and Jirström, Karin}},
  issn         = {{1746-1596}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{Diagnostic Pathology}},
  title        = {{Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.}},
  url          = {{https://lup.lub.lu.se/search/files/3535017/5421754}},
  doi          = {{10.1186/s13000-014-0189-5}},
  volume       = {{9}},
  year         = {{2014}},
}